A concise review of major challenges in the vaccination, diagnosis and treatment of novel coronavirus disease ۲۰۱۹

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 190

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHRAZI-79-6_004

تاریخ نمایه سازی: 17 دی 1403

چکیده مقاله:

The rapid spread of severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) led to ۲۰۱۹ coronavirus (COVID-۱۹) pandemic worldwide. An efficient strategy to control the COVID-۱۹ pandemic includes the rapid recognition of patients and vaccination using accurate and reliable methods. Various diagnostic methods such as CT scan, serology and molecular methods have been applied for the COVID-۱۹ diagnosis. Moreover, various vaccines and antiviral drugs or immunotherapies have been utilized to combat the virus. This is particularly important for COVID-۱۹ patients at high risk of serious consequences. Various challenges in the prognosis, diagnosis, vaccination and treatment of COVID-۱۹ include variability in disease severity, emerging variants, individual factors and immune responses, co-infections and complications, limited long-term data, psychological and social factors, availability and accessibility, tests sensitivity and specificity, variability in symptoms, mild or asymptomatic cases, limited specific antiviral options, clinical heterogeneity, lack of universal treatment protocol, overwhelmed healthcare systems, management of severe cases, long-term effects and post-COVID syndrome, vaccine hesitancy, global cooperation and vaccine production capacity. This article describes the latest challenges and achievements in the prognosis, diagnosis, vaccination and therapy of COVID-۱۹. The consult with reliable sources such as national health authorities and the World Health Organization (WHO) is crucial to obtain the latest information on COVID-۱۹ vaccination, including eligibility, availability, and recommended protocols in any specific region. The treatment options and strategies continue to evolve. Healthcare professionals and researchers are working diligently to address therapy challenges and improve outcomes for individuals affected by COVID-۱۹. Randomized clinical studies designed to identify the most appropriate and proven treatment are essential both to reduce the prevalence of COVID-۱۹ and to prevent the prevalence of any pandemic in the future.

نویسندگان

Nasrin Bargahi

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;

Abdolmajid Ghasemian

Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran

Reyhaneh Hoseinpoor

Department of Biotechnology, School of Advance Technologies in Medicine Shahid Beheshti University, Tehran, Iran

Shirin Mahmoodi

Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Wu F, Zhao S, Yu B, Chen Y-M, Wang W, ...
  • Chary MA, Barbuto AF, Izadmehr S, Hayes BD, Burns MM. ...
  • Wagner CE, Saad-Roy CM, Grenfell BT. Modelling vaccination strategies for ...
  • Meo S, Bukhari I, Akram J, Meo A, Klonoff DC. ...
  • Ioannou GN, Locke ER, Green PK, Berry K. Comparison of ...
  • Adjobimey T, Meyer J, Sollberg L, Bawolt M, Berens C, ...
  • Heidary M, Kaviar VH, Shirani M, Ghanavati R, Motahar M, ...
  • Yalçın TY, Topçu Dİ, Doğan Ö, Aydın S, Sarı N, ...
  • Corey L, Mascola JR, Fauci AS, Collins FS. A strategic ...
  • Araf Y, Akter F, Tang Yd, Fatemi R, Parvez MSA, ...
  • Guglielmi G. Rapid coronavirus tests: a guide for the perplexed. ...
  • Kralik P, Ricchi M. A basic guide to real time ...
  • Yüce M, Filiztekin E, Özkaya KG. COVID-۱۹ diagnosis—a review of ...
  • Merindol N, Pépin G, Marchand C, Rheault M, Peterson C, ...
  • Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays ...
  • Park G-S, Ku K, Baek S-H, Kim S-J, Kim SI, ...
  • Yang W, Dang X, Wang Q, Xu M, Zhao Q, ...
  • Inaba M, Higashimoto Y, Toyama Y, Horiguchi T, Hibino M, ...
  • Jiang M, Pan W, Arasthfer A, Fang W, Ling L, ...
  • Yang W, Restrepo-Pérez L, Bengtson M, Heerema SJ, Birnie A, ...
  • Lee H, Choi J, Jeong E, Baek S, Kim HC, ...
  • Broughton JP, Deng X, Yu G, Fasching CL, Singh J, ...
  • Li S, Huang J, Ren L, Jiang W, Wang M, ...
  • Han C, Li W, Li Q, Xing W, Luo H, ...
  • Lou J, Wang B, Li J, Ni P, Jin Y, ...
  • Sharma A, Balda S, Apreja M, Kataria K, Capalash N, ...
  • Zhou Y, Wu Y, Ding L, Huang X, Xiong Y. ...
  • Mattioli IA, Castro KR, Macedo LJ, Sedenho GC, Oliveira MN, ...
  • Beduk T, Beduk D, de Oliveira Filho JI, Zihnioglu F, ...
  • Yu S, Nimse SB, Kim J, Song K-S, Kim T. ...
  • Xia S, Chen X. Single-copy sensitive, field-deployable, and simultaneous dual-gene ...
  • Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: ...
  • Dotolo S, Esposito Abate R, Roma C, Guido D, Preziosi ...
  • D’Alessandra Y, Valerio V, Moschetta D, Massaiu I, Bozzi M, ...
  • Lewandowski K, Xu Y, Pullan ST, Lumley SF, Foster D, ...
  • Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, ...
  • Gillenwater S, Rahaghi F, Hadeh A. Remdesivir for the treatment ...
  • Furuta Y, Komeno T, Nakamura T. Favipiravir (T-۷۰۵), a broad ...
  • Du YX, Chen XP. Favipiravir: pharmacokinetics and concerns about clinical ...
  • Nukoolkarn V, Lee VS, Malaisree M, Aruksakulwong O, Hannongbua S. ...
  • Yao TT, Qian JD, Zhu WY, Wang Y, Wang GQ. ...
  • Abd‐Elsalam S, Noor RA, Badawi R, Khalaf M, Esmail ES, ...
  • Wan S, Yi Q, Fan S, Lv J, Zhang X, ...
  • In Ah C, Sang Jin L, Won P, Sung Hwan ...
  • Casadevall A, Scharff MD. Serum therapy revisited: animal models of ...
  • Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, ...
  • Zhao J, Yuan Q, Wang H, Liu W, Liao X, ...
  • Shende P, Bhandarkar S, Prabhakar B. Heat shock proteins and ...
  • Golchin A. Cell-based therapy for severe COVID-۱۹ patients: clinical trials ...
  • Tang L, Jiang Y, Zhu M, Chen L, Zhou X, ...
  • Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, ...
  • Bean DM, Kraljevic Z, Searle T, Bendayan R, Kevin OG, ...
  • Fahrni ML, Ismail IA, Refi DM, Almeman A, Yaakob NC, ...
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, ...
  • Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, ...
  • Mukherjee S, Kalra K, Phelan AL. Expanding global vaccine manufacturing ...
  • Vakil MK, Mansoori Y, Al-Awsi GRL, Hosseinipour A, Ahsant S, ...
  • Goldman JD, Robinson PC, Uldrick TS, Ljungman P. COVID-۱۹ in ...
  • Samantaray NN, Kar N, Mishra SR. A follow-up study on ...
  • Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, ...
  • Maniruzzaman M, Islam MM, Ali MH, Mukerjee N, Maitra S, ...
  • Rehman SU, Rehman SU, Yoo HH. COVID-۱۹ challenges and its ...
  • Chilamakuri R, Agarwal S. COVID-۱۹: Characteristics and Therapeutics. Cells. ۲۰۲۱;۱۰(۲) ...
  • Hosseinzadeh S, Ketabi S, Atighehchian A, Nazari R. Hospital bed ...
  • نمایش کامل مراجع